Sympatient
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | - | - | 1.1m | 3.2m | 7.4m |
% growth | - | - | - | 191 % | 131 % |
Profit | (<1m) | (1.1m) | (1.3m) | - | - |
% profit margin | - | - | (121 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | €1.6m | Seed | |
N/A | $1.7m | Seed | |
* | €7.5m | Series A | |
N/A | Early VC | ||
Total Funding | €10.7m |
Recent News about Sympatient
EditSympatient is a pioneering digital healthcare company specializing in the treatment of anxiety disorders through innovative technology. The company primarily serves individuals suffering from agoraphobia, social anxiety disorder, and panic disorder. Operating in the mental health market, Sympatient leverages a combination of mobile applications and virtual reality (VR) to deliver exposure therapy, a standard treatment for anxiety disorders. This approach allows patients to receive high-quality care while enabling therapists to manage their time more effectively and treat patients holistically.
Sympatient's business model is centered around providing subscription-based access to their digital therapy solutions. Revenue is generated through patient subscriptions and partnerships with healthcare providers and institutions. By integrating technology into mental health treatment, Sympatient aims to make therapy more accessible and efficient, ultimately improving patient outcomes.
Keywords: digital healthcare, anxiety disorders, exposure therapy, virtual reality, mobile app, mental health, agoraphobia, social anxiety, panic disorder, subscription model.